Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-03-22
2005-03-22
McKenzie, Thomas C. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
06869956
ABSTRACT:
The present invention describes methods of preventing and treating inflammatory and immune-related diseases or disorders using inhibitors of IκB kinase (IKK). Also described are IKK inhibitors effective for the prevention and treatment of inflammatory and immune-related diseases or disorders, as demonstrated in vivo. Further embodiments of the present invention relate to a specific IKK inhibitors, 4(2′-aminoethyl)amino-1,8-dimethylimidazo(1,2-a) quinoxaline and compounds of formula (I), salts thereof, and pharmaceutical compositions.
REFERENCES:
patent: 4160097 (1979-07-01), Warner, Jr. et al.
patent: 4172947 (1979-10-01), Warner, Jr. et al.
patent: 4191766 (1980-03-01), Warner, Jr. et al.
patent: 4191767 (1980-03-01), Warner, Jr. et al.
patent: 4198508 (1980-04-01), Warner, Jr. et al.
patent: 4200750 (1980-04-01), Warner, Jr. et al.
patent: 4225724 (1980-09-01), Warner, Jr. et al.
patent: 4229452 (1980-10-01), Warner, Jr. et al.
patent: 4236015 (1980-11-01), Warner, Jr. et al.
patent: 5153196 (1992-10-01), McQuaid et al.
patent: 5182386 (1993-01-01), Albaugh et al.
patent: 5196421 (1993-03-01), McQuaid et al.
patent: 6066642 (2000-05-01), Jacobson et al.
patent: 6235740 (2001-05-01), Barrish et al.
patent: WO 9407893 (1994-04-01), None
patent: WO 9717079 (1997-05-01), None
patent: WO 9719079 (1997-05-01), None
patent: WO 9848805 (1998-05-01), None
patent: WO 9943704 (1999-09-01), None
patent: WO 0158890 (2001-08-01), None
patent: WO 0168648 (2001-09-01), None
OneLook® Dictionary Search, [online] 2004, [retrieved on Mar. 15, 2004]. Retrieved from the internet, <http://onelook.com/?w=*&loc=revfp2&clue=%22inflammatory+lung+disease%22>.*
Platz J. and Bals R. Current Medicinal Chemistry—Anti-Inflammatory & Anti-Allergy Agents Mar. 2004, vol. 3, No. 1, pp. 39-52(14), abstract only.*
No Author, Trilateral Project B3b Theme: Comparative study on “reach-through claims” [online]. San Francisco, California, Nov. 5-9, 2001, [retrieved on Jun. 26, 2003]. Ret'd Internet <http://www.uspto.gov/web/tws/B3b_reachthrough.pdf>.*
Arvin et al., Neuroscience and Biobehavioral Reviews, vol. 20 No. 3, pp. 445-452 (1996).
Dinarello, C.A., Journal of Biological Regulators and Homeostatic Agents, vol. 11 No. 3, pp. 91-103 (1997).
Baldwin, A., Annu. Rev. Immunol., vol. 14, pp. 649-681 (1996).
Christman, et al., Chest, vol. 117, pp. 1482-1487 (2000).
Siebenlist et al., Annu. Rev. Cell Biol., vol. 10, pp. 405-455 (1994).
Baeuerle et al., Cell, vol. 87, pp. 13-20 (1996).
Brown et al., Science, vol. 267, pp. 1485-1488 (1995).
Finco et al., Proc. Natl. Acad.Sci., vol. 91, pp. 11884-11888 (1994).
Baldi et al., The Journal of Biological Chemistry, vol. 271, pp. 376-379 (1996).
Roff et al., The Journal of Biological Chemistry, vol. 271, pp. 7844-7850 (1996).
Weil et al., The Journal of Biological Chemistry, vol. 272, pp. 9942-9949 (1997).
Whiteside et al., The EMBO Journal, vol. 16 No. 6, pp. 1413-1426 (1997).
Chen et al., Cell, vol. 84, pp. 853-862 (1996).
Lee et al., Cell, vol. 88, pp. 213-222 (1997).
DiDonato et al., Nature, vol. 388, pp. 548-554 (1997).
Zandi et al., Cell, vol. 91, pp. 243-252 (1997).
Mercurio et al., Science, vol. 278, pp. 860-866 (1997).
Woronicz et al., Science, vol. 278, pp. 866-870 (1997).
Li et al., The Journal of Biological Chemistry, vol. 273 No. 46, pp. 30736-30741 (1998).
Regnier et al., Cell, vol. 90, pp. 373-383 (1997).
Ghoda et al., The Journal of Biological Chemistry, vol. 272 No. 34, pp. 21281-21288 (1997).
Peters et al., Molecular Cell, vol. 5, pp. 513-522 (2000).
Mallnin et al., Nature, vol. 385, pp. 540-544 (1997).
Song et al., Proc. Natl. Acad. Sci., vol. 94, pp. 9792-9796 (1997).
Karin et al., Annual Review of Immunology, vol. 18, pp. 621-663 (2000).
Yin et al., Nature, vol. 396, pp. 77-80 (1998).
Yan et al., The Journal of Biological Chemistry, vol. 274 No. 51, pp. 36631-36636 (1999).
Peskar et al., Digestive Diseases and Sciences, vol. 32 No. 12, pp. 51S-56S (1987).
Horn et al., Scand. J. Gastroenterol., vol. 26, pp. 867-869 (1991).
Yamamoto et al., The Journal of Biological Chemistry, vol. 274 No. 38, pp. 27307-27314 (1999).
Rossi et al., Nature, vol. 403, p. 103-108 (2000).
Kapahi et al., The Journal of Biological Chemistry, vol. 275 No. 46, pp. 36062-36066 (2000).
Colotta et al., Eur. J.Med.Chem., vol. 30, pp. 133-139 (1995).
Ceccarelli et al., Eur. J. Med.Chem., vol. 33, pp. 943-955 (1998).
Li et al., Science, vol. 284, pp. 321-325 (1999).
Hu et al., Science, vol. 284, pp. 316-320 (1999).
Mignani et al., Drug Development Research, vol. 48, pp. 121-129 (1999).
Damour et al., Heterocycles, vol. 50, No. 1, pp. 259-267 (1999).
Witkamp et al., The Veterinary Quarterly, vol. 22 No. 1, pp. 11-16 (2000).
Verma et al., Proc. Natl. Acad. Sci., vol. 94 pp. 11758-11760 (1997).
Burke James R.
Nadler Steven G.
Qiu Yuping
Townsend Robert M.
Zusi Fred Christopher
Bristol--Myers Squibb Company
Lamerdin John A.
McKenzie Thomas C.
Sher Audrey F.
LandOfFree
Methods of treating inflammatory and immune diseases using... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of treating inflammatory and immune diseases using..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating inflammatory and immune diseases using... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3372455